Immatics N.V. (IMTX)
Healthcare
$8.69-2.69%Close
SELLCRISIS · day 3
$8.69-2.69%
Key stats
- Market cap
- $1.2B
- Avg volume
- 466.5K
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Immatics Announces $150 Million Underwritten Offering
Immatics Announces Second Quarter 2026 Financial Results and Business Update
Analysts Set Immatics N.V. (NASDAQ:IMTX) Target Price at $20.80
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
Immatics: PRAME Is Becoming More Than A Single-Asset Story
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
